Search Results - "Aranda ‐Michel, Jaime"
-
1
Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors
Published in Liver transplantation (01-01-2012)“…The use of donation after cardiac death (DCD) liver grafts is controversial because of the overall increased rates of graft loss and morbidity, which are…”
Get full text
Journal Article -
2
Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus
Published in Liver transplantation (01-06-2011)“…Hepatitis C virus (HCV) infection is the most common indication for orthotopic liver transplantation in the United States. Although studies have addressed the…”
Get full text
Journal Article -
3
Liver transplantation and pancreatic resection: A single‐center experience and a review of the literature
Published in Liver transplantation (01-12-2009)“…Liver transplantation may occasionally be indicated in patients with unique clinical scenarios. Little is known regarding the outcomes of patients who have had…”
Get full text
Journal Article -
4
Long-term outcomes of donation after cardiac death liver allografts from a single center
Published in Clinical transplantation (01-03-2009)“…: Organ shortage continues to be a major challenge in transplantation. Recent experience with controlled non‐heart‐beating or donation after cardiac death…”
Get full text
Journal Article -
5
Liver Disease and Osteoporosis
Published in Nutrition in Clinical Practice (01-06-2006)“…Metabolic bone disease (osteodystrophy) is an important complication of patients with chronic liver disease; its etiology is complex and multifactorial…”
Get full text
Book Review Journal Article -
6
Preexisting atrial fibrillation and cardiac complications after liver transplantation
Published in Liver transplantation (01-03-2015)“…Atrial fibrillation (AF) is the most common cardiac arrhythmia, and it is associated with increased cardiovascular morbidity and all‐cause mortality. Our aim…”
Get full text
Journal Article -
7
Peritonitis after liver transplantation: Incidence, risk factors, microbiology profiles, and outcome
Published in Liver transplantation (01-08-2006)“…Peritonitis occurring after liver transplantation (PLT) has been poorly characterized to date. The aims of this study were to define the incidence, risk…”
Get full text
Journal Article -
8
Nutrition for the liver transplant patient
Published in Liver transplantation (01-09-2006)“…Patients with end‐stage liver disease (ESLD) frequently have diverse abnormalities of carbohydrate, lipid, and protein metabolism that cause progressive…”
Get full text
Journal Article -
9
Nutritional support in head injury
Published in Nutrition (Burbank, Los Angeles County, Calif.) (01-02-2011)“…Abstract Nutritional support is imperative to the recovery of head-injury patients. Hypermetabolism and hypercatabolism place this patient population at…”
Get full text
Journal Article -
10
Reversible non-ischaemic cardiomyopathy and left ventricular dysfunction after liver transplantation: a single-centre experience
Published in Liver international (01-07-2014)“…Background & Aims Non‐ischaemic cardiomyopathy (NIC) is an early complication of liver transplantation (LT). Our aims were to define the prevalence, associated…”
Get full text
Journal Article -
11
Gastroparesis: From Concepts to Management
Published in Nutrition in clinical practice (01-08-2013)“…While the symptoms of gastroparesis are common, an accurate diagnosis is based on a combination of those symptoms with a documented delay in gastric emptying…”
Get full text
Journal Article -
12
Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence
Published in Liver transplantation (01-06-2011)“…Factors present prior to liver transplantation (LT) that predict fibrosis progression in recurrent hepatitis C infection (HCV) after LT would be important to…”
Get full text
Journal Article -
13
Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients
Published in Clinical transplantation (01-01-2008)“…: Transplant patients are at increased risk of developing dyslipidemia, which contributes to coronary artery disease and cardiovascular events. The purpose of…”
Get full text
Journal Article -
14
Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival
Published in Liver transplantation (01-12-2007)“…Infection with hepatitis C virus (HCV) is the leading cause of liver transplantation (LT), while liver retransplantation (RT) for HCV is controversial as a…”
Get full text
Journal Article -
15
-
16
Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study
Published in Clinical transplantation (01-12-2005)“…: Background: Liver transplant recipients are at high risk for multi‐drug resistant infections because of broad‐spectrum antibiotic and immunosuppression…”
Get full text
Journal Article -
17
Recurrent liver failure caused by IgG4 associated cholangitis
Published in Annals of hepatology (01-10-2011)“…Immunoglobulin G4 associated cholangitis (IAC) is an autoimmune disease associated with autoimmune pancreatitis (AIP). It presents with clinical and…”
Get full text
Journal Article -
18
Improving graft survival for patients undergoing liver transplantation
Published in Clinical transplantation (01-05-2011)“…Dickson RC, Pungpapong S, Keaveny AP, Taner BC, Ghabril M, Aranda‐Michel J, Satyanarayana R, Bonatti H, Kramer DJ, Nguyen JH. Improving graft survival for…”
Get full text
Journal Article -
19
Dual hepatitis virus infections in liver transplant: case report and a review of the literature
Published in Clinical transplantation (01-03-2009)“…: Background: Liver transplantation (LT) using grafts from anti‐HBVcore antibody‐positive (anti‐HBVcAB+) donors carry risk for development of hepatitis B…”
Get full text
Journal Article -
20
Patient Selection for Liver Transplant: 1-Year Experience With 555 Patients at a Single Center
Published in Mayo Clinic proceedings (01-02-2008)“…Liver transplant (LT) has revolutionized the management of end-stage liver disease in the past 2 decades. The institution of the Model for End-Stage Liver…”
Get full text
Journal Article